Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapieDiabetes MellitusType 2HumansPeroxisome Proliferator-Activated ReceptorsAnimals
Chiglitazar, a PPAR pan-agonist: Impacts on type 2 diabetes mellitus and multi-system metabolic regulation - A review.
Ee Chang, Yiran Zhu, Wei Wei, Jiaxuan Huai, Tiansu Lv, Yan Lou, Xiqiao Zhou
Published: 202510.1016/j.biopha.2025.118850
Abstract
Type 2 diabetes mellitus (T2DM) is a prevalent chronic metabolic disorder with multifactorial pathogenesis involving genetic predisposition, environmental influences, and dietary habits. Insulin resistance represents a central pathophysiological mech…
Preview only. Read the full abstract at the source